玻璃体内注射贝伐单抗治疗对一名脑视网膜血管病变患者增殖性视网膜病变的影响。 - Suppr

Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy.

作者信息

Kernt Marcus, Gschwendtner Andreas, Neubauer Aljoscha S, Dichgans Martin, Haritoglou Christos

出版信息

J Neurol. 2010 Jul;257(7):1213-4. doi: 10.1007/s00415-010-5500-0. Epub 2010 Feb 24.

DOI:10.1007/s00415-010-5500-0

PMID:20179959

Abstract

摘要

相似文献

Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy.

J Neurol. 2010 Jul;257(7):1213-4. doi: 10.1007/s00415-010-5500-0. Epub 2010 Feb 24.

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.

Indian J Ophthalmol. 2009 May-Jun;57(3):241-2. doi: 10.4103/0301-4738.49406.

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

Ophthalmology. 2006 Oct;113(10):1695.e1-15. doi: 10.1016/j.ophtha.2006.05.064.

Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.

J Neuroophthalmol. 2007 Sep;27(3):238-40. doi: 10.1097/WNO.0b013e31814b273d.

Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.

Int Ophthalmol. 2008 Feb;28(1):59-61. doi: 10.1007/s10792-007-9105-2. Epub 2007 Jul 4.

Rapid resolution of severe retinal neovascularisation in proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab (Avastin).

Clin Exp Optom. 2009 Jan;92(1):34-7. doi: 10.1111/j.1444-0938.2008.00295.x.

Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma.

J Trauma. 2010 Mar;68(3):747. doi: 10.1097/TA.0b013e31817d7535.

Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A.

Acta Ophthalmol. 2009 Nov;87(8):930-2. doi: 10.1111/j.1755-3768.2009.01598.x.

Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration.

J Clin Ultrasound. 2010 Feb;38(2):66-70. doi: 10.1002/jcu.20650.

Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization.

Acta Ophthalmol. 2008 Feb;86(1):115-6. doi: 10.1111/j.1600-0420.2007.00977.x. Epub 2007 Aug 2.

引用本文的文献

Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: Critical Role of Retina Specialists.

J Vitreoretin Dis. 2022 Dec 3;7(2):171-177. doi: 10.1177/24741264221129095. eCollection 2023 Mar-Apr.

Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.

Neurology. 2020 Oct 6;95(14):e1918-e1931. doi: 10.1212/WNL.0000000000010659. Epub 2020 Sep 4.

Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Brain. 2016 Nov 1;139(11):2909-2922. doi: 10.1093/brain/aww217.

Genetic stroke syndromes.

Continuum (Minneap Minn). 2014 Apr;20(2 Cerebrovascular Disease):399-411. doi: 10.1212/01.CON.0000446109.20539.68.

[Genetics of ischemic stroke].

Nervenarzt. 2013 Feb;84(2):166-72. doi: 10.1007/s00115-012-3641-3.

Genetic susceptibility to ischemic stroke.

Nat Rev Neurol. 2011 May 31;7(7):369-78. doi: 10.1038/nrneurol.2011.80.

[Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography].

Ophthalmologe. 2011 Feb;108(2):117-23. doi: 10.1007/s00347-010-2226-4.

本文引用的文献

Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.

Curr Opin Ophthalmol. 2009 May;20(3):158-65. doi: 10.1097/ICU.0b013e32832d25b3.

Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.

Am J Ophthalmol. 2009 Jun;147(6):1022-30, 1030.e1-5. doi: 10.1016/j.ajo.2009.01.009. Epub 2009 Mar 27.

Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Retina. 2008 Jul-Aug;28(7):957-63. doi: 10.1097/IAE.0b013e3181754209.

Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy.

Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1699-705. doi: 10.1007/s00417-008-0914-4. Epub 2008 Aug 12.

Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. doi: 10.1097/ICU.0b013e3282f0ca54.

Bevacizumab and retinal ischemia.

Ophthalmology. 2007 Nov;114(11):2096. doi: 10.1016/j.ophtha.2007.05.057.

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.

Nat Genet. 2007 Sep;39(9):1068-70. doi: 10.1038/ng2082. Epub 2007 Jul 29.

Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3.

Am J Hum Genet. 2001 Aug;69(2):447-53. doi: 10.1086/321975. Epub 2001 Jun 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献